临床试验设计的类型
合集下载
相关主题
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Parallel Design
Simultaneous treatment and control groups Each person is randomly assigned to one treatment group Randomization removes treatment selection bias and promotes
Treatment can’t have permanent effects or cures
Potential carry-over effects of first-period treatment to second period
- Washout needs to be long enough - Unequal carry-over effects - Treatment during washout
Surg, 118: 518-528; Fishman, A., & Martinez, F., et al. (2003). N Engl J Med 348: 2059-73.
7
Parallel Design Example: NETT
Hypothesis testing Outcomes
Follow-up Number of recruiting centers
excretion, and toxicity
- Often not controlled
PhaseII:
- Usually 30-100 people - Preliminary information on efficacy, additional information on
safety and side effects
Clusters
- Villages (450) selected using survey sampling method - Each randomly allocated to one treatment
谢谢
Lancet. 1986 May 24;1(8491):1169-73
16
Multi-center (17)
Source: NETT Research Group (1999). Chest 1999; 116: 1750-61; NETT Research Group (1999). J Thorac Cardiovasc
Surg, 118: 518-528; Fishman, A., & Martinez, F., et al. (2003). N Engl J Med 348: 2059-73.
1,200
Randomized
—Lung volume reduction surgery plus medical therapy
—Medical therapy (standard therapy control)
Source: NETT Research Group (1999). Chest 1999; 116: 1750-61; NETT Research Group (1999). J Thorac Cardiovasc
Testing of both treatments in each patient
- Each patient serves as his/her own control - Variability reduced because less variability within patient than
Superiority
—Primary: mortality, exercise capacity —Secondary: quality of life, symptoms,
lung function and mechanics, functional capacity Up to 7.5 years
National Emphysema Treatment Trial (NETT)
- Phase III trial, unmasked
Population Sample size Allocation to treatment Treatments
People with severe emphysema
between patients
Fewer patients needed
9
Crossover Design Graph
Group 1, Tx A
Group 2, Tx A
Group 2, Tx B
Washout
Group 1, Tx B
10
Crossover Design: Disadvantages
12
Crossover Design: Examples
Evening-dose vs. morning-dosed travoprost in open-angle glaucoma for 24-hour intraocular pressure control
Montelukast vs. salmeterol as adjuvant to inhaled fluticasone for exercise-induced asthma in children
Topical oil vs. placebo for neuropathic pain
13
Group Allocation Design
Also known as “cluster randomization”
Randomization unit is a group of individuals (community, school, clinic)
PhaseIII:
- Usually 100+ people - Assess efficacy and safety - Controlled, usually randomized
2
Lecture Outline
Discuss various trial design types
- Parallel - Crossover - Group allocation - Factorial - Large simple - Equivalency - Non-inferiority - Adaptive
Baidu Nhomakorabea14
l
α[ I j 川 臼
Randomized
〈
〈
15
Group Allocation Example: Sommer Vit A trial
Population
- Preschool children in northern Sumatra in 1982-83
Treatments
- Vitamin A supplementation during study - Vitamin A supplementation after study
- Chronic diseases—asthma, hypertension, arthritis
Short-term treatment effects
- Relief of signs or symptoms of disease
Metabolic, bioavailability, or tolerability studies
comparability of treatment groups Statistical comparisons made between treatment groups
5
|P 叫 ωe巾 G
Randomized
「
占
,白
1
v
iJHSPH
6
Parallel Design Example: NETT
主讲人:
Copyright © 2013 Johns Hopkins University and Lea Drye. All Rights Reserved.
Phases of trials
PhaseI:
- First stage in testing a new intervention in humans - Usually 10-30 people - Identify tolerable dose, provide information on drug metabolism,
Individual randomization and intervention is not feasible or is unacceptable
- Tracking - Contamination
If there is a correlation in the responses within a group, design loses some efficiency (more individuals required)
3
Section A
Comparison Structure: Parallel, Crossover, and Group Allocation Designs
The material in this video is subject to the copyright of the owners of the material and is being provided for educational purposes under rules of fair use for registered students in this course only. No additional copies of the copyrighted work may be made or distributed.
Test for period by treatment interactions not powerful
Dropouts more significant
Analysis may be more difficult
11
Crossover Design: Uses
Constant intensity of underlying disease
8
Crossover Design
Randomization of order in which treatments are received
- AB or BA - Randomization promotes balance between treatment groups in
timing of exposure